Presented by
Management Forum
Learn how to navigate the regulatory system of veterinary pharmaceuticals in China
The market demand for veterinary drugs in China is substantial. However, companies must navigate the regulatory barrier due to China’s distinct and separate regulatory system.
This course aims to provide practical advice and guidance on successfully obtaining market approval for veterinary drugs in China. Participants will gain a comprehensive understanding of the necessary requirements.
Throughout the programme, expert speakers will elucidate relevant regulations, and registration procedures through presentations, while also addressing participant questions.
This course is part of our Regulatory Affairs Training course collection, which features updates on the latest regulations to registration procedures and strategies.
This event will be beneficial to companies interested in expanding into the Chinese markets, as well as to registration personnel responsible for market approval matters:
You may also be interested in our Animal Feed and Feed Additive Registration in China and Thailand course running on the same day!
Bi Jun is a pharmaceutical expert with more than 10 years of experience in health product development and registration in China. Currently in Knoell Shanghai, he is mainly responsible for regulatory support and the registration of pharmaceutical ingredients and packaging materials for human drugs (DMF), Biocides, feed/feed additives and veterinary drugs.
Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to: